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We thank Dr. Ng and coworkers [1] for their interest in our
article and for the insights about the importance of nutri-
tional screening as a way to prevent surgical site infections
(SSIs). We totally agree with the suggestion of Ng et al.
that nutritional counseling should be completed with
screening for early detection of insulin resistance before
major digestive surgery.
Overt diabetes is strongly associated with a higher rate
of SSIs [2]. The hyperglycemic postsurgical stress response
has been associated with an increased risk of SSIs in
nondiabetic patients also [3]. Intensive postoperative gly-
cemia control has been shown to improve outcomes in
nondiabetic cardiovascular patients [4], general surgery
patients [5], and critically ill patients [6]. We could spec-
ulate that patients with metabolic syndrome and insulin
resistance might probably benefit from a stringent protocol
of glycemia control initiated in the early postoperative
phase. As outlined in the recent Cochrane Review [7], there
is insufficient evidence to support the use of strict glycemic
control in the intra- and postoperative periods for the pre-
vention of SSIs. Nevertheless, it is our current practice
to apply strict glycemic control to all patients who spend
the first 24–48 h in the ICU after major operations
(e.g., esophagectomy, pancreatic resection, and major
hepatectomy).
Our survey has shown an overall low adherence of
surgeons to using measures to prevent SSIs irrespective of
the level of scientific evidence. Thus, should a preoperative
screening for insulin resistance be part of the presurgery
workup by the operating surgeon or should it be the role of
the general practitioner taking care of the patient?
The lack of stringent evidence about the protective role
of early detection of metabolic syndrome and other factors
specifically connected to health-care reimbursement poli-
cies might hamper its implementation. Prospective
assessment of the cost effectiveness of a systematic pres-
urgery insulin resistance workup and systematic glycemic
control on the SSI rate could be a valuable tool, pro-
vided that well-known risk factors and confounders are
controlled.
Today’s surgical practice is mainly developed outside
the OR to improve quality of care and offer patients a
tailored postoperative management. Enhanced surgical
community attention to preoperative nutritional status
assessment is a rather difficult task but one that we consider
worthy. We recently published a meta-analysis on the role
played by immunonutrition on the postoperative outcomes,
and results favor the liberal use of this measure [8]. Fur-
thermore, a prospective randomized clinical trial on the
effects of immunonutrition on SSIs is currently ongoing at
our General and Visceral Surgery Department.
To conclude, although blood sweetness appears delete-
rious for the surgical patient, it would, without doubt, be
sweet to reduce SSI rates.
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